- Report
- March 2021
- 64 Pages
India
- Report
- October 2019
India
- Report
- June 2019
- 71 Pages
Global
€2582EUR$2,950USD£2,244GBP
- Report
- November 2023
- 120 Pages
Global
From €4070EUR$4,650USD£3,538GBP
- Report
- April 2023
- 35 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- February 2023
- 152 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- September 2022
- 110 Pages
Global
From €4813EUR$5,500USD£4,184GBP
- Report
- June 2022
- 124 Pages
Global
From €4813EUR$5,500USD£4,184GBP
- Report
- December 2022
- 66 Pages
Global
From €3063EUR$3,500USD£2,663GBP
- Report
- November 2024
- 198 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- December 2024
- 170 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- July 2024
- 150 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- June 2024
- 137 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- May 2024
- 137 Pages
United States
From €5207EUR$5,950USD£4,527GBP
- Report
- January 2024
- 125 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- September 2023
- 168 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- May 2022
- 100 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- February 2025
- 206 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- October 2024
- 202 Pages
Global
From €2144EUR$2,450USD£1,864GBP
- Report
- January 2025
- 70 Pages
Australia
From €4070EUR$4,650USD£3,538GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more